50 million people suffer from epilepsy around the World. According to the WHO, this chronic disease accounts for 0.5% of the global burden of disease.
BioSerenity is a company specialized in developing mobile neurology diagnostic devices. Their first product, the Neuronaute uses smart clothing to allow monitoring and diagnosis of epilepsy. Developed by their team of engineers and designers in cooperation with neurologists, this solution simplifies monitoring for healthcare professionals and allows for long term in or outpatient monitoring.
BioSerenity just won the worldwide innovation contest 2030. Founded in January 2014, the company is located within the Brain and Spine Institute (icm-institute.org) in Paris. With offices in Lyon and Troyes, reaching more than 60 employees, the company is internationalizing and has opened branches in the United States: Atlanta, GA and Boston, MA.